alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
UNAUDITED CONSOLIDATED BALANCE SHEET AND STATEMENTS OF INCOME, WHICH ARE
INCLUDED IN THE COMPANY'S FORM 10-QSB FILED HEREWITH, AND IS QUALIFIED IN ITS
ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                              91
<SECURITIES>                                         0
<RECEIVABLES>                                      383
<ALLOWANCES>                                       (5)
<INVENTORY>                                        499
<CURRENT-ASSETS>                                 1,066
<PP&E>                                           2,302
<DEPRECIATION>                                 (1,555)
<TOTAL-ASSETS>                                   2,133
<CURRENT-LIABILITIES>                            1,145
<BONDS>                                            163
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           862
<OTHER-SE>                                          25
<TOTAL-LIABILITY-AND-EQUITY>                     2,133
<SALES>                                          4,012
<TOTAL-REVENUES>                                 4,012
<CGS>                                            2,121
<TOTAL-COSTS>                                    1,803
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                  78
<INCOME-PRETAX>                                     33
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                 33
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                        33
<EPS-BASIC>                                       0.03
<EPS-DILUTED>                                     0.03


</TABLE>
<PAGE>

                  ------------------------------------------
                                AMENDEMENT No 1
                       STYRENE MONOMER SUPPLY AGREEMENT
                       BETWEEN STYROCHEM AND ELF ATOCHEM
                  ------------------------------------------



Elf Atochem agrees to extend the first termination notice from October 14/th/
1999 to December 31/st/ 1999.

At the same time the validity of the contract shall be extended from October
14/th/ 2000 to December 31/st/ 2000.

All the other articles included in the styrene monomer supply agreement
concluded between Elf Atochem and Styrochem on January 1998 shall remained
unchanged.


Date: 24/11/99                                    Date: 01/12/99
Elf Atochem

/s/ Eric Quenet                                   /s/ Thomas L. Springer
---------------------                             -----------------------------
Eric QUENET                                       Thomas L. SPRINGER


--------------------
   Elf Atochem SA
--------------------


   [ILLEGIBLE]^^
--------------------
Exhibit 23.1







CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM








We consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333-138323, 333-61572, 333-57742 and 333-65673) of Young Innovations, Inc. of our report dated March 11, 2011, relating to the consolidated financial statements and schedule, and the effectiveness of internal control over financial reporting, appearing in the Annual Report on Form 10-K of Young Innovations, Inc. for the year ended December 31, 2010.











/s/ Crowe Horwath LLP


Oak Brook, Illinois


March 11, 2011
* Pursuant to 5TH CIR. R. 47.5, the court has determined

that this opinion should not be published and is not precedent

except under the limited circumstances set forth in 5TH CIR.

R. 47.5.4.

IN THE UNITED STATES COURT OF APPEALS

FOR THE FIFTH CIRCUIT

 

No. 97-30504

Conference Calendar

 

DAVID L. DAVIES,

Plaintiff-Appellant,

versus

RICHARD EDWARDS, JR., Sheriff, Jefferson

Davis Parish, ET AL.,

Defendants-Appellees.

- - - - - - - - - -

Appeal from the United States District Court

for the Western District of Louisiana

USDC No. 96-CV-1603

- - - - - - - - - -

June 17, 1998

Before DAVIS, PARKER, and DENNIS, Circuit Judges.

PER CURIAM:*

David L. Davies, Louisiana inmate #361176, appeals the

district court’s dismissal, with prejudice, for frivolousness of

his claims concerning unlawful detention and deprivation of

property. Davies argues the following issues which were

presented to the district court: the claims had not prescribed

because accrual occurred within the year from the date on which

he filed his suit, and the doctrine of contra non valentem agere
No. 97-30504

-2-

non currit praescripto applies to his case and prevented

prescription from running. For the first time on appeal Davies

argues the following: prescription cannot run against a

plaintiff who is incarcerated, and his claims involve continuing

torts which prevented prescription from running. 

We have carefully reviewed these arguments and the appellate

record. We conclude that the district court did not abuse its

discretion in determining that Davies’ claims are frivolous

because they have prescribed. See McCormick v. Stalder, 105

F.3d 1059, 1061 (5th Cir. 1997). The issues raised for the first

time on appeal do not amount to plain error. See Highlands Ins.

v. National Union Fire Ins., 27 F.3d 1027, 1031-32 (5th Cir.

1994).

AFFIRMED.
### TEXAS COURT OF APPEALS, THIRD DISTRICT, AT AUSTIN

JUDGMENT RENDERED AU GUST 31, 2016

NO. 03

- 15

- 00221

- CR

Michael Grace, Appellant

v.

The State of Texas, Appellee

APPEAL FROM COUNTY COURT AT LAW NO. 6 OF TRAVIS COUNTY

BEFORE CHIEF JUSTICE ROSE, JU STICES PEMBERTON AND FIELD

AFFIRMED

-- OPINION BY JUSTICE PEMBERTON

This is an appeal from the judgment signed by the trial court. Having reviewed the record and

the parties’ argu ments, the Court holds that there was no reversible error in the trial court’s

judgment . Therefore, the Court affirms the trial court’s judgment

. Because appellant is indigent

and unable to pay c osts, no adjudication of costs is made.
|   | 1.     | Such Annual Report on Form 10-K for the year ending December 31, 2010 fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and                                      |
|--------|--------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|   |   |                                                                                                                                                                                                                  |
|   | 2.     | The information contained in such Annual Report on Form 10-K for the fiscal year ended December 31, 2010 fairly presents, in all material respects, the financial condition and results of operations of the Company. |

|   | /s/ Yonglin Du                |
|--------|-------------------------------|
|   | Yonglin Du                    |
|   | President & CEO           |
|   | (Principal Executive Officer) |

----
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
FINANCIAL STATEMENTS IN THE QUARTERLY REPORT ON FORM 10-QSB OF AUDIOHIGHWAY.COM
FOR THE THREE MONTHS ENDED JUNE 30, 2000 AND IS QUALIFIED IN ITS ENTIRETY BY
REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                           1,473
<SECURITIES>                                     2,000
<RECEIVABLES>                                      356
<ALLOWANCES>                                         0
<INVENTORY>                                        420
<CURRENT-ASSETS>                                 4,581
<PP&E>                                           1,186
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                                   6,849
<CURRENT-LIABILITIES>                            1,823
<BONDS>                                            134
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                        34,717
<OTHER-SE>                                    (29,825)
<TOTAL-LIABILITY-AND-EQUITY>                     6,849
<SALES>                                          1,497
<TOTAL-REVENUES>                                 1,497
<CGS>                                              948
<TOTAL-COSTS>                                   10,324
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                (41)
<INCOME-PRETAX>                                (8,786)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                            (8,786)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (8,786)
<EPS-BASIC>                                     (1.40)
<EPS-DILUTED>                                   (1.40)


</TABLE>
CERTIFICATION PURSUANT TO 18 U.S.C.
 SECTION 1350, AS ADOPTED PURSUANT TO
 SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
 
 
 In connection with the Annual Report of Bullion River Gold Corp. (Bullion River) on Form 10-KSB for the period ending December 31, 2003 as filed with the Securities and Exchange Commission on the date hereof (the Report), I, Peter M. Kuhn, President and Chief Executive Officer of Bullion River and a member of the Board of Directors, certify, pursuant to s.906 of the Sarbanes-Oxley Act of 2002, that:
 
 (1)   The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
 
 (2)   The information contained in the Report fairly represents, the financial condition and result of operations of the Company.
 
 /s/ Peter M. Kuhn
 Peter M. Kuhn
 Chief Executive Officer
 April 7, 2004
 
 Page - 46
 
 CERTIFICATION PURSUANT TO 18 U.S.C.
 SECTION 1350, AS ADOPTED PURSUANT TO
 SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
 
 
 In connection with the Annual Report of Bullion River Gold Corp. (Bullion River) on Form 10-KSB for the period ending December 31, 2003 as filed with the Securities and Exchange Commission on the date hereof (the Report), I, Peter M. Kuhn, Secretary, Treasurer, and Chief Financial Officer of Bullion River and a member of the Board of Directors, certify, pursuant to s.906 of the Sarbanes-Oxley Act of 2002, that:
 
 (1)   The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
 
 (2)   The information contained in the Report fairly represents, the financial condition and result of operations of the Company.
 
 /s/ Peter M. Kuhn
 Peter M. Kuhn
 Chief Financial Officer
 April 7, 2004
#### In re HARPER. In the matter of Nancy M. Harper.

(Supreme Court, Appellate Division, First Department.

February 18, 1898.)

T. Cleveland, for appellant.

J. M. Perry, for respondent.

No opinion. Order affirmed, with $10 costs and disbursements.
II 

Calendar No. 120 

112TH CONGRESS 

1ST SESSION S. 409 

To ban the sale of certain synthetic drugs. 

IN THE SENATE OF THE UNITED STATES 

FEBRUARY 17, 2011 

Mr. SCHUMER (for himself, Mr. KYL, Mr. KOHL, Mr. SESSIONS, Mrs. FEINSTEIN, Mr. WHITEHOUSE, Ms. KLOBUCHAR, Mr. FRANKEN, Mr. 

BLUMENTHAL, Mr. BROWN of Ohio, Mr. CASEY, Mr. LAUTENBERG, Mr. 

MANCHIN, Mr. WYDEN, and Mr. LEAHY) introduced the following bill; 

which was read twice and referred to the Committee on the Judiciary 

JULY 28, 2011 

Reported by Mr. LEAHY, without amendment 

A BILL 

To ban the sale of certain synthetic drugs. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Combating Dangerous 

5 Synthetic Stimulants Act of 2011’’. 


pwalker on DSK5TPTVN1PROD with BILLS
2 

•S 409 RS

1 SEC. 2. CONTROLLED SUBSTANCES ACT. 

2 Schedule I of section 202(c) of the Controlled Sub3 stances Act (21 U.S.C. 812(c)) is amended in subsection 

4 (c) by adding at the end the following: 

5 ‘‘(18) 4-methylmethcathinone (Mephedrone). 

6 ‘‘(19) 3,4-methylenedioxypyrovalerone 

7 (MDPV).’’. 


pwalker on DSK5TPTVN1PROD with BILLS

pwalker on DSK5TPTVN1PROD with BILLS
Calendar No. 120 

112TH CONGRESS 

1ST SESSION S. 409 

A BILL 

To ban the sale of certain synthetic drugs. 

JULY 28, 2011 

Reported without amendment 


pwalker on DSK5TPTVN1PROD with BILLS
**UN PUBLISHED** 
UNITED STATES COURT OF APPEALS FOR THE FOURTH CIRCUIT

**No. 12**  **- 6205** 

UNITED STATES OF AMERICA , Plaintiff

– Appellee ,
v. SEAN MCKARN, a/k/a Mack , Defendant

- Appellant
.

Appeal from the United States District Court for the Northern District of West Virginia , at Wheeling
. Frederick P. Stamp, Jr. , Senior District Judge. ( 5:99

- cr - 00011

- F PS

- JES

- 6 )

Submi t ted : May 31 , 2012 Decided: June 6, 2012

Before KING, DUNCAN, and D I A Z , Circuit Judges.

Affirmed by un published per curiam opinion
. Sean McKarn, Appellant Pro Se. Robert Hugh McWilliams, Jr., John Castle Parr, Assistant United States Attorneys, Wheeling, West Virginia, for Appellee.
Unpublished opinions are not binding precedent in this circuit.2 PER CURIAM:
Sean McKarn appeals the district court’s order denying h is motion seeking a reduction of sentence under 18 U.S.C.
§ 3582 (2006) . We have reviewed the record and find no reversible error, given that McKarn is ineligible for the reduction that he seeks. Accordi ngly, we affirm the judgment of the district court. United States v. McKarn , No. 5:99

- cr - 00011

- FPS

- JES

- 6 (N.D.W. Va. Jan. 17, 2012)
. We dispense with oral argument because the facts and legal contentions are adequately presented in the materials before t he court and argument would not aid the decisional process.

AFFIRMED
Exhibit 32.1









Certification of Principal Executive Officer

Pursuant to 18 U.S.C. 1350

(Section 906 of the Sarbanes-Oxley Act of 2002)





I, Yonglin Du, President and Chief Executive Officer of Dahua Inc. (the "Company") do hereby certify, pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge, based upon a review of the Annual Report on Form 10-KSB for the year ended December 31, 2007 of the Company, as filed with the Securities and Exchange Commission on the date hereof (the "Report"):



(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and





(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.







|                              | 
|----------------------------- | 
|By: /s/ Yonglin Du            | 
|Yonglin Du, President & CEO   | 
|(Principal Executive Officer) | 
|                              | 
|March 28, 2007                |
# C_2020201EN.01002002.xml

| 15.6.2020 | EN | Official Journal of the European Union | C 201/20 |
| --- | --- | --- | --- |

15.6.2020

EN

Official Journal of the European Union

C 201/20

---

Judgment of the General Court of 29 April 2020 — Cimpress Schweiz v EUIPO — Impress Media (CIMPRESS)

(Case T-37/19) (1)

(EU trade mark - Opposition proceedings - Application for EU word mark CIMPRESS - Earlier EU figurative mark impress - Earlier national word mark Impress-Media - Relative ground for refusal - Likelihood of confusion - Article 8(1)(b) of Regulation (EU) 2017/1001)

(2020/C 201/29)

Language of the case: German

Parties

Applicant: Cimpress Schweiz GmbH (Winterthur, Switzerland) (represented by: C. Eckhartt, P. Böhner and A. von Mühlendahl, lawyers)

Defendant: European Union Intellectual Property Office (represented by: A. Söder, acting as Agent)

Other party to the proceedings before the Board of Appeal of EUIPO, intervener before the General Court: Impress Media GmbH (Mönchengladbach, Germany) (represented by: F. Remmertz, lawyer)

Re:

Action brought against the decision of the Second Board of Appeal of EUIPO of 30 October 2018 (Joined Cases R 1716/2017-2 and R 1786/2017-2) relating to opposition proceedings between Impress Media and Cimpress Schweiz.

Operative part of the judgment

The Court:

| 1. | Authorises Impress GmbH to replace Impress Media GmbH as intervener; |
| --- | --- |

1.

Authorises Impress GmbH to replace Impress Media GmbH as intervener;

| 2. | Dismisses the action; |
| --- | --- |

2.

Dismisses the action;

| 3. | Orders Cimpress Schweiz GmbH to bear its own costs and pay the costs incurred by the European Union Intellectual Property Office (EUIPO) and Impress. |
| --- | --- |

3.

Orders Cimpress Schweiz GmbH to bear its own costs and pay the costs incurred by the European Union Intellectual Property Office (EUIPO) and Impress.

---

(1)  OJ C 82, 4.3.2019.

---
<PAGE>
                                                                    EXHIBIT 32.1

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

         In connection with the Annual Report of Noble Corporation (the
"Company") on Form 10-K for the period ended December 31, 2004, as filed with
the United States Securities and Exchange Commission on the date hereof (the
"Report"), I, James C. Day, Chairman, Chief Executive Officer and President of
the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

         (1)      The Report fully complies with the requirements of section
                  13(a) or 15(d) of the Securities Exchange Act of 1934; and

         (2)      The information contained in the Report fairly presents, in
                  all material respects, the financial condition and results of
                  operations of the Company.

March 8, 2005                    /s/ JAMES C. DAY
                                 -----------------------------------------------
                                 James C. Day
                                 Chairman, Chief Executive Officer and President
                                 of Noble Corporation
#### Benedetto Galioto et al., Appellants, v Joseph Galioto, Respondent.

In an action to recover on a debt, plaintiffs appeal from an order of the Supreme Court, Dutchess County (Wood, J.), dated August 17, 1984, which denied their motion pursuant to CPLR 3213 for summary judgment in lieu of complaint and granted defendant’s cross motion for summary judgment dismissing the action.

Order reversed, on the law, with costs, motion granted, and cross motion denied.

The instrument upon which the plaintiffs have sued meets all the requisites of a note (UCC 3-104 [1], [2] [d], [3]; *Carnwright v Gray,*127 NY 92). The fact that payment becomes due upon such an instrument only on the debtor’s death does not render it an invalid attempt at a substitute for a testamentary disposition *(Hegeman v Moon,*131 NY 462) unless the instrument involves a gift without consideration rather than a contract *(McCarthy v Pieret,*281 NY 407; *Matter of Laytin,*149 Misc 60; *cf Matter of Gallagher,*153 NY 364). The instrument in this case specifically acknowledges the debt and the purposes for which the proceeds of the loan from plaintiffs had been or were to be used, namely upon home improvements. Clearly there was consideration for the decedent’s promise to pay embodied in the note.

Since the note was not payable on demand but only by decedent’s estate upon her death, the plaintiffs’ cause of action *149accrued, and the Statute of Limitations began to run, on August 1, 1983, the day following her death (UCC 3-122 [1] [a]).

Accordingly, the action was timely commenced in May 1984. Mollen, P. J., Titone, O’Connor and Rubin, JJ., concur.
# C_2020027EN.01001602.xml

| 27.1.2020 | EN | Official Journal of the European Union | C 27/16 |
| --- | --- | --- | --- |

27.1.2020

EN

Official Journal of the European Union

C 27/16

---

Request for a preliminary ruling from the Amtsgericht Nürnberg (Germany) lodged on 21 October 2019 — Myflyright GmbH v SunExpressGünes Ekspres Havacilik A

(Case C-770/19)

(2020/C 27/21)

Language of the case: German

Referring court

Amtsgericht Nürnberg

Parties to the main proceedings

Applicant: Myflyright GmbH

Defendant: SunExpressGünes Ekspres Havacilik A

The case was removed from the register of the Court of Justice by order of the President of the Court of 11 November 2019.

---
Exhibit
32.1
  SECTION
1350 CERTIFICATION


In
connection with the Quarterly Report of Med-Emerg International Inc. (the
"Company") on Form 10-Q for the period ending March 31, 2008 as filed with the
Securities and Exchange Commission on the date hereof (the "Report"), the
undersigned hereby certifies, pursuant to 18 U.S.C. § 1350, , to the best of
such officer’s knowledge, that:


1)           The
Report fully complies with the requirements of section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and


2)           The
information contained in the Report fairly presents, in all material respects,
the financial condition and result of operations of the
Company.


Dated:
May 12, 2008







By:
            /s/
      Ramesh ZachariasName:
      Dr. Ramesh ZachariasTitle:
      Chief Executive Officer (Principal Executive
  Officer)